Plasma 8-iso-prostaglandin F2α , a marker of oxidative stress, is increased in patients with acute myocardial infarction

被引:42
作者
Elesber, AA
Best, PJ
Lennon, RJ
Mathew, V
Rihal, CS
Lerman, LO
Lerman, A
机构
[1] Mayo Clin & Mayo Fdn, Div Cardiovasc Med, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Div Biostat, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Div Nephrol & Hypertens, Rochester, MN 55905 USA
关键词
oxidative stress; myocardial infarction; isoprostanes; artherosclerosis;
D O I
10.1080/10715760500539154
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Oxidative stress has been implicated in the pathogenesis of atherogenesis. The aim of our study is to examine whether the plasma 8-iso-prostaglandin F-2 alpha level, a marker of oxidative stress, is elevated in patients with acute myocardial infarction. Methods: Three groups of patients were enrolled: (1) patients with no or minimal coronary artery disease (CAD) (n = 15); (2) patients with stable CAD (n = 31); (3) patients with acute myocardial infarction (n = 13). Results: Plasma 8-iso-prostaglandin F-2 alpha levels were significantly elevated (p < 0.001) in patients with acute myocardial infarction (290.7 +/- 73.9 pg/ ml) as compared to patients with stable CAD (182.0 + 75.7 pg/ ml) and patients with no significant CAD (118.9 +/- 85.5 pg/ ml). This remained significant after correcting for coronary atherosclerosis risk factors, age, extent of atherosclerosis, and C-reactive protein (CRP) level. Conclusion: Plasma 8-iso-prostaglandin F-2 alpha levels are elevated in patients with acute myocardial infarction. Endogenous oxidative stress may contribute to the pathogenesis of atherosclerosis and its complications, namely myocardial infarction.
引用
收藏
页码:385 / 391
页数:7
相关论文
共 40 条
  • [21] LIPID-PEROXIDATION AND PROTECTIVE ENZYMES DURING MYOCARDIAL-INFARCTION
    LOEPER, J
    GOY, J
    ROZENSZTAJN, L
    BEDU, O
    MOISSON, P
    [J]. CLINICA CHIMICA ACTA, 1991, 196 (2-3) : 119 - 125
  • [22] EFFECT OF OXYGEN-TENSION ON THE GENERATION OF F-2-ISOPROSTANES AND MALONDIALDEHYDE IN PEROXIDIZING RAT-LIVER MICROSOMES
    LONGMIRE, AW
    SWIFT, LL
    ROBERTS, LJ
    AWAD, JA
    BURK, RF
    MORROW, JD
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 47 (07) : 1173 - 1177
  • [23] Atherosclerosis
    Lusis, AJ
    [J]. NATURE, 2000, 407 (6801) : 233 - 241
  • [24] INCREASE IN CIRCULATING PRODUCTS OF LIPID-PEROXIDATION (F-2-ISOPROSTANES) IN SMOKERS - SMOKING AS A CAUSE OF OXIDATIVE DAMAGE
    MORROW, JD
    FREI, B
    LONGMIRE, AW
    GAZIANO, JM
    LYNCH, SM
    SHYR, Y
    STRAUSS, WE
    OATES, JA
    ROBERTS, LJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (18) : 1198 - 1203
  • [25] NON-CYCLOOXYGENASE-DERIVED PROSTANOIDS (F2-ISOPROSTANES) ARE FORMED INSITU ON PHOSPHOLIPIDS
    MORROW, JD
    AWAD, JA
    BOSS, HJ
    BLAIR, IA
    ROBERTS, LJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) : 10721 - 10725
  • [26] A SERIES OF PROSTAGLANDIN-F2-LIKE COMPOUNDS ARE PRODUCED INVIVO IN HUMANS BY A NONCYCLOOXYGENASE, FREE RADICAL-CATALYZED MECHANISM
    MORROW, JD
    HILL, KE
    BURK, RF
    NAMMOUR, TM
    BADR, KF
    ROBERTS, LJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (23) : 9383 - 9387
  • [27] Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion
    O'Byrne, S
    Forte, P
    Roberts, LJ
    Morrow, JD
    Johnston, A
    Änggård, E
    Leslie, RDG
    Benjamin, N
    [J]. DIABETES, 2000, 49 (05) : 857 - 862
  • [28] Connecting the role of C-reactive protein and statins in cardiovascular disease
    Ridker, PM
    [J]. CLINICAL CARDIOLOGY, 2003, 26 (04) : 39 - 44
  • [29] Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
    Ridker, PM
    Cushman, M
    Stampfer, MJ
    Tracy, RP
    Hennekens, CH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (14) : 973 - 979
  • [30] Urinary 8-iso-prostaglandin F2α as a risk marker in patients with coronary heart disease -: A matched case-control study
    Schwedhelm, E
    Bartling, A
    Lenzen, H
    Tsikas, D
    Maas, R
    Brümmer, J
    Gutzki, FM
    Berger, J
    Frölich, JC
    Böger, RH
    [J]. CIRCULATION, 2004, 109 (07) : 843 - 848